Status:
RECRUITING
University of Michigan "Nephrology Research BioBank"
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
amfAR, The Foundation for AIDS Research
Regeneron Pharmaceuticals
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
Brief Summary
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Detailed Description
Each year chronic kidney disease (CKD) claims the lives of millions of people worldwide. Costs for patient care are in excess of 2.4 billion dollars in the US alone. At the moment most kidney diseases...
Eligibility Criteria
Inclusion
- Men, women and children undergoing kidney and/or pancreas biopsy at the University of Michigan
Exclusion
- Individuals not willing to provide consent (for prospective biopsy)
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2030
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT00381121
Start Date
September 1 2006
End Date
August 1 2030
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109